Skip to content

Christine Mikail Cvijic, President and CFO at Neurogene, sold NGNE on Jul 1, 2026

Data as of Oct 27

▼ SELL$25.2K739 shares at $34.06Christine Mikail Cvijic President and CFONGNE Neurogene Inc.
Watch NGNE
Traded
Jul 1, 2026
Disclosed
Jul 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Christine Mikail Cvijic, President and CFO at Neurogene, sold NGNE on Jul 1, 2026TRADEDDISCLOSED
NGNESimilar stocks (XLV — its sector index fund), rebased to NGNE's price on the disclosure day
NGNE since disclosure
−23.6%
after the sale
Similar stocks (XLV) since disclosure
+9.4%
XLV — its sector index fund

Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLChristine Mikail Cvijic President and CFONGNE Neurogene Inc.$53.9Kdisclosed Jul 2 · filed the same day
  2. ▼ SELLChristine Mikail Cvijic President and CFONGNE Neurogene Inc.$87.5Kdisclosed Jul 2 · filed the same day

See every trade on NGNE →